key: cord-0929776-vef431jg
authors: Zaffina, Salvatore; Lanteri, Paola; Gilardi, Francesco; Garbarino, Sergio; Santoro, Annapaola; Vinci, Maria Rosaria; Carsetti, Rita; Scorpecci, Alessandro; Raponi, Massimiliano; Magnavita, Nicola; Camisa, Vincenzo
title: Recurrence, Reactivation, or Inflammatory Rebound of SARS-CoV-2 Infection With Acute Vestibular Symptoms: A Case Report and Revision of Literature
date: 2021-08-11
journal: Front Hum Neurosci
DOI: 10.3389/fnhum.2021.666468
sha: 04014eb85615ccd252f644c1dc400ca1b732cf38
doc_id: 929776
cord_uid: vef431jg

A case of recurrent coronavirus disease 2019 (COVID-19) with neurovestibular symptoms was reported. In March 2020, a physician working in an Italian pediatric hospital had flu-like symptoms with anosmia and dysgeusia, and following a reverse transcription PCR (RT/PCR) test with a nasopharyngeal swab tested positive for SARS-CoV-2. After home quarantine, 21 days from the beginning of the symptoms, the patient tested negative in two subsequent swabs and was declared healed and readmitted to work. Serological testing showed a low level of immunoglobulin G (IgG) antibody title and absence of immunoglobulin M (IgM). However, 2 weeks later, before resuming work, the patient complained of acute vestibular syndrome, and the RT/PCR test with mucosal swab turned positive. On the basis of the literature examined and reviewed for recurrence cases and vestibular symptoms during COVID-19, to our knowledge this case is the first case of recurrence with vestibular impairment as a neurological symptom, and we defined it as probably a viral reactivation. The PCR retest positivity cannot differentiate re-infectivity, relapse, and dead-viral RNA detection. Serological antibody testing and viral genome sequencing could be always performed in recurrence cases.

In China, in December 2019, the epidemic caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) rapidly diffused all over the world leading to a pandemic. While the coronavirus disease 2019 typically presents as a self-limiting respiratory disease, and in hospitalized patients, the clinical picture is dominated by respiratory distress (Del Sole et al., 2020) , progression to severe illness with multiorgan involvement, including the blood vessels, heart, gut, kidneys, testicles, and brain has been reported (Asadi-Pooya and Simani, 2020; Ibrahim, 2020; Leonardi et al., 2020; Nepal et al., 2020) . Patients suffering from COVID-19 can develop acute or long-term neurological sequelae (Ellul et al., 2020) . The prevalence of neuro-COVID varies considerably between individual studies ranging from 4.1% to 57.4% (Romero-Sánchez et al., 2020) and even 84% in COVID-19 with acute respiratory distress syndrome (Helms et al., 2020) . The onset of nervous system damage can be asynchronous with systemic manifestations and the typically salient severe respiratory disease (Vavougios, 2020) .

In our pediatric hospital, between March and May 2020, there were 25 cases of COVID-19 among healthcare workers (HCWs), equal to 1.1% of the total staff. Two of them had at least one symptom, namely, headache, anosmia, and dysgeusia or all the three symptoms at the same time. These neurological symptoms indicate that the virus, like other respiratory viruses (Bohmwald et al., 2018) , enters the central nervous system (CNS) through the olfactory bulb causing inflammation. Furthermore, SARS-CoV-2 viruses can spread from the mechano-and chemo-receptors in the lungs and lower respiratory airways to the medullary cardiorespiratory center via a synapse-connected route .

In this study, we report a case of recurrent SARS-CoV-2 infection with neurovestibular involvement, review literature cases with vestibular involvement, and discuss the neurotropism of this virus based on literature data.

A 48-year-old female physician in a pediatric hospital presented cough, slight dyspnea, severe myalgia, asthenia, and headache on March, 2020, followed by anosmia and dysgeusia over the following few days (Figure 1 ) without fever. When symptoms appeared the worker self-isolated at home. The allergic rhinitis the patient suffers from led to a short delay in diagnosis; however, a swab carried out 8 days from the beginning of the symptoms tested positive for SARS-CoV-2 (Allplex TM 2019-nCoV Assay). In subsequent days, the patient felt better and became asymptomatic. On days 23 and 27 the patient was retested and was negative both times. On day 37, serology was performed by ELISA and a low level of immunoglobulin G (IgG) against SARS-CoV-2 was detected. Immunoglobulin M (IgM) search was negative. She was feeling well and was declared fit to work by the occupational physician of the hospital. However, before returning to work, on day 39 the patient woke up experiencing intensive dizziness, described as subjective vertigo, associated with vomiting and bilateral aural fullness (Figure 1) . The dizziness quickly got worse as the patient lied supine on the right side. She was transported by ambulance to the emergency room of a hospital where dizzying syndrome was diagnosed and treated with metoclopramide. Physical examination revealed normal vital signs, while the patient was breathing ambient air. Some relevant auxiliary examinations such as blood routine, coagulation function, liver and renal function, electrolytes, and inflammation indicators were completed, and the results were normal. After 3 h and the improvement of the symptoms, she was discharged home, cared by health public service, and treated with betahistine dihydrochloride for 1 week. The day after, on day 40, a nasal swab was obtained, which tested positive.

In the following days, the dizziness disappeared and only a mild postural instability persisted, whereas aural fullness was unchanged. The only pathology that she suffered from was allergic rhinitis. She had never suffered from dizziness in the past.

An ear, nose, and throat (ENT) visit took place on day 44. Otoscopy was negative. Romberg, Unterberger (March-inplace), and finger-to-nose tests were negative. Neither bedside vestibular examination with Frenzel glasses showed spontaneous nystagmus, nor was nystagmus evoked by supine position, Dix-Hallpike maneuver, lateral head rotation, and Rose position. The head-shaking test was negative. The only relevant finding of the vestibular examination was the patient complaining about slight dizziness during the Dix-Hallpike maneuver on the right side (supine position with the head hyperextended and tilted to the right side). The patient did not develop fever both in the first and in the second phase of the symptoms related to COVID-19. Despite fever being one of the most common symptoms of COVID-19, it may be absent in some individuals. Finally, the patient was completely healed without any deficit and was able to return to work.

The case reported presents numerous points of interest. First, the recurring nature of the symptoms must be emphasized along with the neurological origin of the symptoms themselves. Second, the neurotropism and neuroinvasive potential of the virus into recurrence mode should be considered. Finally, the observation that the presence of anti-spike IgG has been followed by a positive PCR test; this feature is rather infrequent, having been found in 0.13 per 10,000 days at risk in HCWs, whereas the probability of having a positive PCR test in the anti-spike-seronegative HCWs is significantly higher (1.09 per 10,000 days at risk) (Lumley et al., 2020) .

The presence of at least two consecutive negative RT-PCR tests in respiratory samples (with samples taken at least 24 h apart) and the appearance of specific IgG at serological test, according to the discharge criteria of the European Centre for Disease Prevention and Control (Yahav et al., 2021) , permits to classify the case exposed as recurrent COVID-19 with multiple district neurological symptoms (vestibular symptoms, previously anosmia and dysgeusia). Indeed reinfection should be considered during the first 90 days if clinical symptoms of the first episode resolve and two PCR tests were negative before the new episode (Yahav et al., 2021) .

Currently, there are numerous reports that a number of patients tested positive again after two consecutive negative PCR tests or after clinical recovery ( Table 1 ) (Falahi and Kenarkoohi, 2020) . Nasopharyngeal swabs tend to have a higher sensitivity than the other samples and are the most common method for diagnosis of COVID-19 recurrence, regardless of the clinical disease manifestation. With the progression of SARS-CoV-2 infection, the virus could migrate from the upper respiratory tract to the lower respiratory tract and lungs, resulting in insufficient viral load in the upper respiratory tract, which may explain the negative result of the nasopharyngeal swab test. The detection rate and sensitivity have been improved by multisite specimen collection and serological assays ( Table 1 ). The prevalence of disease recurrence among COVID-19 recovered patients was approximately 14.8%, ranging from 7.35 to 21.4% (Azam et al., 2020; Hoang, 2020) . The interval duration from the last negative PCR tests to recurrent positive results ranged from 1 to 123 days (min average 16.16 ± 20.93 ds, max average 25.39 ± 23.00 ds) for 1,038 cases in a selected population of 13,565 patients ( Table 1) . The case described experienced at the onset two of the three typical symptoms in the first phase of infection, namely, cough (68%) and shortness of breath (66%) without fever (69%). About 92% of the patients experienced at least one of these, less frequently in women (66, 64, 66 respectively; 90% at least one of these; vs. men 70, 67, 71; 93%, each p < 0.001) (ISARIC Clinical Characterisation Group, 2021) . She presented symptoms of recurrence 17 days from the last negative PCR tests, in accordance with the literature. True reinfection has criteria that must be considered, including isolation of the complete genome of the virus (and not just genomic fragments) in the second episode (Falahi and Kenarkoohi, 2020 ), but we did not have this data. In our patient, we could suspect a viral reactivation due to low level of IgG against SARS-CoV-2 detected, even without lymphopenia. It is also possible that the immune responses can suppress, but not completely eradicate, SARS-CoV-2, which may have led to the false-negative results due to lower viral loads . Once the virus starts replicating again, the RT-PCR results reverted to positive and expressed as a new neuroinvasion in the vestibular system. NeuroCovid is now well-known (Whittaker et al., 2020) , but recurrence of positive RT-PCR with neurological symptoms is very rare and no further instances of vestibular symptoms are described as recurrence ( Table 1) . To our knowledge, this is the first case of vestibular symptoms as recurrence of positive RT-PCR SARS-CoV-2. This case shows the neuroinvasive potentials of SARS-CoV-2 and the possibility of disease reactivation after clinical and analytic recovery. SARS-CoV-2 might be latent in some neurons to hide from immune surveillance (Brandt and Dieterich, 2017; Zhang M. et al., 2020) . For reasons unclear, after an apparent remission the virus reactivated and was again identifiable in the respiratory tract. At the same time, the multiplication in the nervous system caused recurrence with intense neurological disturbance, clinically highlighted by dizziness associated with slight dyspnea.

The clinical picture and subsequent ENT are compatible with a diagnosis of the spontaneous acute vestibular syndrome. The most common cause is an acute peripheral vestibulopathy known as vestibular neuritis, affecting the vestibular nerve or "pseudoneuritis" if the acute lesions affect the root entry zone of the eighth nerve or the vestibular nucleus .

The neuroinvasive potential of SARS-CoV-2 is highlighted by some studies (Baig, 2020; Magnavita et al., 2020) .

A relapse of the disease with the involvement of the nervous system may indicate that the virus can be neurotropic since the beginning of the disease or in its recurrence form.

The virus may reach the central nervous system via the olfactory nerve. Olfactory and gustatory dysfunctions without rhinorrhea or nasal obstruction are distinctive of patients with mild-to-moderate COVID-19 infection (Baig, 2020; Cooper et al., 2020; Magnavita et al., 2020; Paniz-Mondolfi et al., 2020; , leading to speculation regarding the olfactory nerve as a possible route of the central nervous system entry.

Dizziness is a common onset symptom of COVID-19 ( Table 2) . This symptom is often considered a non-specific neurological manifestation and is not actively researched or Table 2) . Vertigo should be investigated in SARS-CoV-2 patients and considered along with neurological signs induced by the invasion of the vestibular pathway from the nerve to the vestibular nuclei complex. It is plausible to hypothesize that if the SARS-CoV-2 can also reach the brain from the lungs through the vagus nerve, the virus will invade the brainstem starting with the vagal nucleus and surrounding sites, including the respiratory control center and more, which can lead to more respiratory dysfunction that further exacerbates the damage caused by the primary infection in the lungs or others neurological symptoms (Lukiw et al., 2020; Yachou et al., 2020) , such as vestibular impairment. This hypothesis is supported by the evidence of the presence of a consistent angiotensin-converting enzyme (ACE2) expression across the cerebral cortex. The highest ACE2 expression was found in the pons and the medulla oblongata (Guan et al., 2020) . Indeed, SARS-CoV-2 appears to bind exclusively to the ACE2 protein, a single-pass type 1 transmembrane receptor with its enzymatically active domain exposed on the surface of multiple cell types, such as type II alveolar cells of the respiratory system, enterocytes and intestinal epithelial cells, endothelial cells, epithelial cells of the conjunctival epithelium, kidney cells (renal tubules), and certain immune cells, such as the alveolar monocytes/macrophages and certain cells of the CNS including those of the cerebral cortex, especially the brainstem (Zubair et al., 2019; Chigr et al., 2020; Kabbani and Olds, 2020; Li M. et al., 2020; Panupattanapong and Brooks, 2020; 154) . The highest levels of ACE2-expression in the brain were found in the pons and medulla oblongata, the breathing centers of the brain, which may in part explain the unusually strong ability of SARS-CoV-2 to disrupt normal respiration and pulmonary manifestations including shortness of breath, impaired breathing, and severe respiratory distress. Significant neuroinvasion involving SARS-CoV-2 has been reported from both patients and experimental animals, where the brainstem was heavily infected from apparent spreading via a synapseconnected route to the medullary cardiorespiratory centers (Panupattanapong and Brooks, 2020) . A limitation of this case consists of the absence of magnetic resonance documentation of vestibular impairment and the genetic characterization of the viruses at the onset and recurrence of COVID-19. The rapid resolution of clinical symptoms within a few days and the trend of not submitting the non-hospitalized patient to neuroimaging exam above all in patients with low suspicions of CNS disease and plan for outpatient ENT visit in the pandemic period, prompted the emergency physician not to proceed. Several causes for repositive tests for SARS-CoV-2 in COVID-19 patients during the recovery period have been described. They include false RT-PCR results or positive due to traces of the RNA genome, intermittent virus shedding, viral reactivation in people with low antibody levels or immunity, reinfection with another SARS-CoV-2 strain, an acute severe systemic inflammatory response known as cytokine release syndrome (CRS), or exposure to a contaminated environmental surface after discharge Dao et al., 2021) . Various molecular diagnostic assays have been developed and used worldwide, but the differences in their diagnostic performances remain poorly understood (Matsumura et al., 2020; Liotti et al., 2021; Wang M. et al., 2021) . Most of the articles do not report the commercial kit used for RT-PCR, and, where reported, the sensitivity and specificity data for the kit is not often available in the literature ( Table 1) . All the assays exhibited a specificity of 100%, while sensitivity varied ( Table 1) . The RT-PCR test cannot distinguish between live and dead viruses, but most recurrence of positive RT-PCR is expressed in an asymptomatic way; therefore likely due to dead viruses. We did not perform a genetic characterization of the viruses in order to distinguish between reinfection and reactivation of SARS-CoV-2 in our repositive patient.

This case is suggestive of colonization of the nervous system that can also result in clinical manifestations in cases of recurrence witnessing the diffusion or permanence of SARS-CoV-2 in the nervous system. It also suggests the neurotrophic hypothesis with the possibility of brainstem invasion (pons and medulla oblongata) and the possibility of recurrence with a SARS-CoV-2 positive RT-PCR test and of clinical recurrence with specific neurological symptoms.

Neurological symptoms should be sought and typified in each SARS-CoV-2 patient.

With the outbreak of COVID-19, to better manage the current phase of the pandemic, we should be vigilant for the presence of any neurological symptoms, both as an onset and as a recurrence of infection.

On the basis of the literature examined and reviewed, for recurrence cases and vestibular symptoms during COVID-19, to our knowledge, this is the first case of recurrence with vestibular impairment as neurological symptom, and we suspect it is likely due to viral reactivation. The PCR retest positivity cannot differentiate between reinfectivity and relapse, and dead-viral RNA detection, serological antibody testing, and viral genome sequencing could be always performed in recurrence cases.

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethical review and approval was not required for the study on human participants in accordance with the local legislation and institutional requirements. The patients/participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.

All authors equally contributed to the conception and design of the study. All the authors agreed on the previous version of the manuscript, read, and approved the final manuscript.

Post discharge positive re-tests in COVID-19: common but clinically non-significant

Recurrence of SARS-CoV-2 infection with a more severe case after mild COVID-19, reversion of RT-qPCR for positive and late antibody response: case report

Clinical characteristics of recovered COVID-19 patients with re-detectable positive RNA test

Central nervous system manifestations of COVID-19: a systematic review

Recurrent SARS-CoV-2 RNA positivity after COVID-19: a systematic review and meta-analysis

Neurological manifestations in COVID-19 caused by SARS-CoV-2

New IgM seroconversion and positive RT-PCR test after exposure to the virus in recovered COVID-19 patient

Neurologic alterations due to respiratory virus infections

The dilemma of COVID-19 recurrence after clinical recovery

The dizzy patient: don't forget disorders of the central vestibular system

The clinical characteristic of eight patients of COVID-19 with positive RT-PCR test after discharge

Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patients

Positive conversion of COVID-19 after two consecutive negative RT-PCR results: a role of low-dose CT

Recurrence of positive SARS-CoV-2 RNA in COVID-19: a case report

Clinical course and risk factors for recurrence of positive SARS-CoV-2 RNA: a retrospective cohort study from Wuhan

Clinical characteristics of rehospitalized patients with COVID-19 in China

Epidemiological and clinical findings of short-term recurrence of severe acute respiratory syndrome coronavirus 2 ribonucleic acid polymerase chain reaction positivity in 1282 discharged coronavirus disease 2019 cases: a multicenter, retrospective, observational study

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

A systematic review of neurological symptoms and complications of COVID-19

Reevaluation of retested nucleic acid-positive cases in recovered COVID-19 patients: Report from a designated transfer hospital in Chongqing

Bilateral sudden sensorineural hearing loss and intralabyrinthine hemorrhage in a patient with COVID-19

Autonomic brain centers and pathophysiology of COVID-19

COVID-19 and tinnitus

COVID-19 and the chemical senses: supporting players take center stage

Neurological manifestations of COVID-19 and other coronaviruses: a systematic review

Recurrent COVID-19 in a patient with ulcerative colitis on vedolizumab therapy

Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review

Acute profound sensorineural hearing loss after COVID-19 pneumonia

Features of severe COVID-19: a systematic review and metaanalysis

Positive results for patients with COVID-19 discharged form hospital in Chongqing

Exploring the clinical association between neurological symptoms and COVID-19 pandemic outbreak: a systematic review of current literature

A case presentation for positive SARS-CoV-2 RNA recurrence in a patient with a history of type 2 diabetes that had recovered from severe COVID-19

Serial CT features in discharged COVID-19 patients with positive RT-PCR re-test

Prevalence and outcomes of re-positive nucleic acid tests in discharged COVID-19 patients

Is novel coronavirus 2019 reinfection possible? Interpreting dynamic SARS-CoV-2 test results

Neurological associations of COVID-19

A first case of acute cerebellitis associated with coronavirus disease (COVID-19): a case report and literature review

COVID-19 reinfection: prolonged shedding or true reinfection?

Case report: recurrent clinical symptoms of COVID-19 in healthcare professionals: a series of cases from Brazil

New type of corona virus induced acute otitis media in adult

Letter to the Editor: three cases of redetectable positive SARS-CoV-2 RNA in recovered COVID-19 patients with antibodies

Absent immune response to SARS-CoV-2 in a 3-month recurrence of coronavirus disease 2019 (COVID-19) case

Recurrent positive nucleic acid detection in a recovered COVID-19 patient: a case report and literature review

Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature

Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound?

China Medical Treatment Expert Group for Covid-19. clinical characteristics of coronavirus disease 2019 in China

Longer duration of SARS-CoV-2 infection in a case of mild COVID-19 with weak production of the specific IgM and IgG antibodies

Rate of re-positive RT-PCR test among patients recovered from COVID-19

Decreased B cells on admission associated with prolonged viral RNA shedding from the respiratory tract in coronavirus disease 2019: a case-control study

Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review

Neurologic features in severe SARS-CoV-2 infection

Systematic review and meta-analysis of factors associated with re-positive viral RNA after recovery from COVID-19

Recurrent positive reverse transcriptase-polymerase chain reaction results for coronavirus disease 2019 in patients discharged from a hospital in China

Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing

Recurrence of SARSCoV-2 PCR positivity in COVID-19 patients: a single center experience and potential implications

Neurological manifestations in coronavirus disease 2019 (COVID-19) patients: a systematic review of literature

Frequency of neurological presentations of coronavirus disease in patients presenting to a tertiary care hospital during the 2019 coronavirus disease pandemic

COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study. Infection 1-17

Recurrent PCR positivity after hospital discharge of people with coronavirus disease 2019 (COVID-19)

Does COVID19 infect the brain?

South Korea's COVID-19 infection status: from the perspective of re-positive test results after viral clearance evi-denced by negative test results

A prospective clinical study of detailed neurological manifestations in patients with COVID-19

Vertigo and hearing loss during the COVID-19 pandemic -is there an association?

Findings From Investigation and Analysis of Re-Positive Cases

Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss

Nervous system involvement in coronavirus disease 2019: results from a retrospective consecutive neuroimaging cohort

A 67-year-old woman with sudden hearing loss associated with SARS-CoV-2 infection

Positive RT-PCR test results in patients recovered from COVID-19

Positive RT-PCR nasopharyngeal swab in patients recovered from COVID-19 disease: when does quarantine really end?

Neurological manifestations associated with COVID-19: a review and a call for action

Chest CT study of fifteen COVID-19 patients with positive RT-PCR retest results after discharge

SARS-CoV-2 positivity in a discharged COVID-19 patient: a case report

Expression of the SARSCoV-2 cell receptor gene ACE2 in a wide variety of human tissues

Positive result of Sars-Cov-2 in faeces and sputum from discharged patients with COVID-19 in Yiwu

The neuroinvasive potential of SARSCoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients

Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients

Evaluation of three commercial assays for SARS-CoV-2 molecular detection in upper respiratory tract samples

Recovered COVID-19 patients with recurrent viral RNA exhibit lower levels of anti-RBD antibodies

Chest CT and clinical follow-up of discharged patients with COVID-19 in Wenzhou City

18F-FDG PET/CT and serial chest CT findings in a COVID-19 patient with dynamic clinical characteristics in different period

Positive SARS-CoV-2 RNA recurs repeatedly in a case recovered from COVID-19: dynamic results from 108 days of follow-up

Changes in serum virus-specific IgM/IgG antibody in asymptomatic and discharged patients with reoccurring positive COVID-19 nucleic acid test (RPNAT)

Recurrent positive SARS-CoV-2: immune certificate may not be valid

Recurrence of COVID-19 after recovery: a case report from Italy

Evolution of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau

Clinical, immunological and virological characterization of COVID-19 pa-tients that test re-positive for SARS-CoV-2 by RT-PCR

Recurrent COVID-19 pneumonia in the course of chemotherapy: consequence of a weakened immune system?

SARS-CoV-2 infectivity and neurological targets in the brain

Antibody status and incidence of SARS-CoV-2 infection in health care workers

Symptoms in health care workers during the COVID-19 epidemic. a cross-sectional survey

Otologic dysfunction in patients with COVID-19: a systematic review

Congenital inner ear abnormalities and COVID-19-related ear infections

A case of COVID-19-induced vestibular neuritis

Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study

COVID-19 infection recurrence presenting with meningoencephalitis

Comparison of 12 molecular detection assays for SARS-CoV-2

Assessment of patients who tested positive for COVID-19 after recovery

Characteristics and early prognosis of COVID-19 infection in fracture patients

Otolaryngological manifestations of hospitalised patients with confirmed COVID-19 infection

Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)

New spectrum of COVID-19 manifestations in children: Kawasaki-like syndrome and hyperinflammatory response

Seven discharged patients turning positive again for SARS-CoV-2 on quantitative RT-PCR

Re-positive cases of nucleic acid tests in discharged patients with COVID-19: a follow-up study

Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China

Reactivation of COVID-19 pneumonia: a report of two cases

Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry

Recurrent Sars-Cov-2 infection resulting in acute respiratory distress syndrome and development of pulmonary hypertension: a case report

Contentious issue in recurrent COVID-19 infection: reactivation or reinfection

Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran

A patient with asymptomatic SARS-CoV-2 infection who presented 86 days later with COVID-19 pneumonia possibly due to reinfection with SARS-CoV-2

Dizziness can be an early sole clinical manifestation for COVID-19 infection: a case report

Hearing loss and COVID-19: a note

Mediastinal emphysema, giant bulla, and pneumothorax developed during the course of COVID-19 pneumonia

The treatment and follow-up of 'recurrence' with discharged COVID-19 patients: data from Guizhou

COVID-19 re-infection by a phylogenetically distinct SARScoronavirus-2 strain confirmed by whole genome sequencing

SARS-CoV-2 dysregulation of PTBP1 and YWHAE/Z gene expression: a primer of neurodegeneration

Tinnitus and equilibrium disorders in COVID-19 patients: preliminary results

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirusinfected pneumonia in Wuhan -China

Rehospitalization of a recovered coronavirus disease 19 (COVID-19) child with positive nucleic acid detection

Analytical performance evaluation of five RT-PCR kits for severe acute respiratory syndrome coronavirus 2

Clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort study

Neurological manifestations of COVID-19: a systematic review and current update

Probable causes and risk factors for positive SARS-CoV-2 test in recovered patients: evidence from Brunei Darussalam

Discontinuation of antiviral drugs may be the reason for recovered COVID-19 patients testing positive again

Coronavirus disease 2019 test results after clinical recovery and hospital discharge among patients in China

Nervous system involvement after infection with COVID-19 and other coronaviruses

False negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: rather than recurrence

Exploration of turn-positive RT-PCR results and factors related to treatment outcome in COVID-19: a retrospective cohort study

False negative rate of COVID-19 is eliminated by using nasal swab test

Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China

New onset neurologic events in people with COVID-19 in 3 regions in China

Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2, understanding the neurological manifestations in COVID-19 patients

Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity

Viral RNA level, serum antibody responses, and transmission risk in recovered COVID-19 patients with recurrent positive SARS-CoV-2 RNA test results: a population-based observational cohort study

Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation

Reactivation of SARSCoV-2 after recovery

Recurrence of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during medical isolation observation

PCR assays turned positive in 25 discharged COVID-19 patients

Positive rectal swabs in young patients recovered from coronavirus disease 2019 (COVID-19)

SARS-CoV-2 turned positive in a discharged patient with COVID-19 arouses concern regarding the present standards for discharge

The nervous system-A new territory being explored of SARS-CoV-2

Case Report: recurrence of positive SARS-CoV-2 results in patients recovered from COVID-19

Characteristics of children with reactivation of SARS-CoV-2 infection after hospital discharge

A case series of recurrent viral RNA positivity in recovered COVID-19 Chinese patients

Epidemiological and clinical characteristics of COVID-19 patients in Hengyang

Clinical features of COVID-19 convalescent patients with re-positive nucleic acid detection

ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection

Recurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: a case report

Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients

Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review

August 2021 | Volume 15 | Article 666468 Author Disclaimer: As for FG, Medical Director of the Italian Ministry of Health, the opinion and contents expressed in the study are the sole responsibility of the author, and they are not attributable in any way to the institutional and functional positions held by the same at the Italian Ministry of Health (Article 12, paragraph 6, of the Code of Conduct of the Italian Ministry of Health, adopted with DM March 6, 2015 and later).

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.Publisher's Note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.Copyright © 2021 Zaffina, Lanteri, Gilardi, Garbarino, Santoro, Vinci, Carsetti, Scorpecci, Raponi, Magnavita and Camisa. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.